Chi-Kuan et al. revealed that LECT2 antagonizes activation of MET receptor by recruiting the protein tyrosine phosphatase 1B to inhibit the vascular invasion of HCC. The gene discussed is LECT2; the disease is hepatocellular carcinoma.